stockcue

FDMT (4D Molecular Therapeutics, Inc.): Stockcue Score 56/100 — Mixed profile · Valuation 38/100 · Financial health 48/100 · Growth 85/100 · price $10.26. Full report with peer comparison, earnings trends and AI analysis below.

Fetching report — first lookup can take ~5s